FDA, cGMP, GLP, and DEA accreditation. Tests Pharma, Cosmetics, Nutraceuticals, and more. Revenue: $1.4M, Discretionary Earnings:$526K, Asking Price:$2.6M.
Validated for Molecular Detection of Pathogens and Covid-19. Debt-free. Can optionally provide customization and complete management. $550K Asking Price.
The lab has a diversified Revenue Stream from Toxicology, Women’s Health, UTI, Covid, and Respiratory Panel Testing. The lab is well-positioned to continue to grow post-Covid. Projected 2021 Revenue: $6M, EBITDA: $2M.
The Company is specialized in the design, assembly, service, programming and certification of flow rate calibration equipment. Revenue: $1.87M; EBITDA: $650K (proj. for next 12 months).
4.000 sq. ft of lab space available for lease as of Dec 1, 2020. Currently running as a clinical lab doing toxicology and other clinical testing.
The Lab has very stable revenues, is consistently profitable with high EBITDA margins and offers a high growth opportunity. Revenue: $1.21M; EBITDA: $608K; asking price: $2.25M.